Phibro Animal Health (NASDAQ:PAHC) Downgraded by Zacks Research to Hold

Zacks Research lowered shares of Phibro Animal Health (NASDAQ:PAHC) from a strong-buy rating to a hold rating in a report released on Tuesday morning,Zacks reports.

Separately, Weiss Ratings upgraded shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, November 2nd. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $46.50.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $35.15 on Tuesday. The business’s 50-day moving average price is $36.89 and its 200 day moving average price is $40.93. Phibro Animal Health has a twelve month low of $28.25 and a twelve month high of $60.08. The company has a market capitalization of $1.43 billion, a PE ratio of 14.00 and a beta of 0.42. The company has a current ratio of 3.20, a quick ratio of 1.28 and a debt-to-equity ratio of 1.70.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.01. The firm had revenue of $386.77 million for the quarter, compared to analyst estimates of $382.42 million. Phibro Animal Health had a return on equity of 35.88% and a net margin of 6.66%. On average, research analysts predict that Phibro Animal Health will post 3.48 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 16th. Stockholders of record on Wednesday, November 25th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 25th. This represents a $0.48 annualized dividend and a dividend yield of 1.4%. Phibro Animal Health’s payout ratio is currently 19.12%.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in PAHC. Renaissance Technologies LLC boosted its holdings in Phibro Animal Health by 5.8% in the first quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock valued at $31,899,000 after acquiring an additional 31,435 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Phibro Animal Health by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 507,852 shares of the company’s stock worth $28,086,000 after purchasing an additional 15,517 shares during the period. Advisors Asset Management Inc. purchased a new stake in shares of Phibro Animal Health during the 3rd quarter worth about $20,546,000. Allspring Global Investments Holdings LLC grew its holdings in shares of Phibro Animal Health by 145.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 286,172 shares of the company’s stock worth $15,671,000 after purchasing an additional 169,628 shares during the period. Finally, Boston Partners purchased a new stake in shares of Phibro Animal Health during the 3rd quarter worth about $10,907,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation develops and markets products for animal health and nutrition. Its portfolio includes vaccines, medicated feed additives, and nutritional specialty products designed to support the health and productivity of livestock and other animals. The company also supplies trace minerals and related products used in animal nutrition and other applications. Its products serve markets including poultry, cattle, swine, and aquaculture, and are sold to customers in the United States and internationally.